Supporting the Rise of Cell & Gene Therapies – UK and New Jersey Perspectives
Registration is now closed. Please email alicia@onenucleus.com to be added to the waitlist.
Cell and gene therapies are here to stay as medicines that are helping to provide opportunities to patients with high unmet medical need. Whilst an exciting environment, there are many challenges with innovation and commercialisation to be overcome. Collaboration, no doubt, will help to overcome some of these. In this session there will be a facilitated Q&A with leading executives from New Jersey and the UK discussing the current landscape, challenges and opportunities in the field of cell and gene therapies. This will be followed by a breakout session were there will be further chance for delegates to make introductions and discuss the key points raised in the preceding fireside chat.
Programme:
15.00 – Welcome from One Nucleus, BioNJ and Choose New Jersey
15.10 – Meet the KOL fireside chat
Moderator
Dr Tony Jones, CEO, One Nucleus
Speakers
Dr Anne Lane, CEO, UCLB
Dr Stuart Peltz, CEO, PTC Therapeutics
15.40 – Breakout Networking
16.00 – Return to the main room for closing poll
16.10 – Poll results and closing remarks
16.15 – Close
London, SW1X 7EE
United Kingdom